151 related articles for article (PubMed ID: 9370050)
1. Cholinergic activity and amyloid precursor protein metabolism.
Roberson MR; Harrell LE
Brain Res Brain Res Rev; 1997 Sep; 25(1):50-69. PubMed ID: 9370050
[TBL] [Abstract][Full Text] [Related]
2. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling.
Rossner S; Ueberham U; Schliebs R; Perez-Polo JR; Bigl V
Prog Neurobiol; 1998 Dec; 56(5):541-69. PubMed ID: 9775403
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic immunolesions by 192IgG-saporin--useful tool to simulate pathogenic aspects of Alzheimer's disease.
Rossner S
Int J Dev Neurosci; 1997 Nov; 15(7):835-50. PubMed ID: 9568532
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic activity and amyloid precursor protein processing in aging and Alzheimer's disease.
Zhang X
Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):137-52. PubMed ID: 15078189
[TBL] [Abstract][Full Text] [Related]
5. Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.
Schliebs R
Neurochem Res; 2005; 30(6-7):895-908. PubMed ID: 16187224
[TBL] [Abstract][Full Text] [Related]
6. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
[TBL] [Abstract][Full Text] [Related]
8. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic innervation in neuritic plaques.
Struble RG; Cork LC; Whitehouse PJ; Price DL
Science; 1982 Apr; 216(4544):413-5. PubMed ID: 6803359
[TBL] [Abstract][Full Text] [Related]
10. Amyloid deposition in the nucleus basalis of Meynert complex: a topographic marker for degenerating cell clusters in Alzheimer's disease.
Arendt T; Taubert G; Bigl V; Arendt A
Acta Neuropathol; 1988; 75(3):226-32. PubMed ID: 3348080
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease.
Ahmed T; Zahid S; Mahboob A; Farhat SM
Curr Neuropharmacol; 2017; 15(4):480-494. PubMed ID: 27012953
[TBL] [Abstract][Full Text] [Related]
12. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome.
Granholm AC; Sanders L; Seo H; Lin L; Ford K; Isacson O
Hippocampus; 2003; 13(8):905-14. PubMed ID: 14750653
[TBL] [Abstract][Full Text] [Related]
13. Using the subcortically lesioned rat cortex to understand the physiological role of amyloid precursor protein.
Wallace W; Haroutunian V
Behav Brain Res; 1993 Nov; 57(2):199-206. PubMed ID: 8117425
[TBL] [Abstract][Full Text] [Related]
14. Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors.
Hellström-Lindahl E
Eur J Pharmacol; 2000 Mar; 393(1-3):255-63. PubMed ID: 10771022
[TBL] [Abstract][Full Text] [Related]
15. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
17. [beta-Amyloid, cholinergic neurons and Alzheimer's disease].
Kasparová J; Dolezal V
Cesk Fysiol; 2002 May; 51(2):82-94. PubMed ID: 12053492
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins.
Pavía J; de Ceballos ML; Sanchez de la Cuesta F
Fundam Clin Pharmacol; 1998; 12(5):473-81. PubMed ID: 9794144
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
[TBL] [Abstract][Full Text] [Related]
20. Fimbria-fornix lesion does not affect APP levels and amyloid deposition in the hippocampus of APP+PS1 double transgenic mice.
Liu L; Ikonen S; Tapiola T; Tanila H; van Groen T
Exp Neurol; 2002 Oct; 177(2):565-74. PubMed ID: 12429202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
